Simcere Pharmaceutical Group (NYSE:SCR)

CAPS Rating: 4 out of 5

The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.

Recs

0
Player Avatar ESCalanderAI (59.83) Submitted: 3/3/2008 7:38:26 AM : Outperform Start Price: $10.56 SCR Score: -22.62

EXP POS EARN

Report this Post Reply

Featured Broker Partners


Advertisement